4.7 Editorial Material

How Would You Manage This Male Patient With Hypogonadism? Grand Rounds Discussion From Beth Israel Deaconess Medical Center

期刊

ANNALS OF INTERNAL MEDICINE
卷 174, 期 8, 页码 1133-+

出版社

AMER COLL PHYSICIANS
DOI: 10.7326/M21-2524

关键词

-

向作者/读者索取更多资源

Male hypogonadism is characterized by abnormally low serum testosterone concentration or sperm count. As men age, their serum testosterone levels may decrease, and normalizing these levels could improve symptoms related to androgen deficiency.
Male hypogonadism is defined as an abnormally low serum testosterone concentration or sperm count. As men age, often in the context of obesity and other comorbid conditions, serum testosterone levels may decrease. Normalizing serum testosterone levels in male adults with hypogonadism may improve symptoms related to androgen deficiency, but controversies exist regarding the long-term benefits and risks of hormone supplementation in this setting. In 2020, the American College of Physicians published a clinical guideline for the use of testosterone supplementation in adult men based on a systematic review of available evidence. Among their recommendations were that clinicians discuss whether to initiate testosterone treatment in men with age-related low testosterone with sexual dysfunction who want to improve sexual function and not initiate testosterone treatment in men with age-related low testosterone to improve energy, vitality, physical function, or cognition. Here, two clinicians with expertise in this area, one a generalist and the other an endocrinologist, debate the management of a patient with sexual symptoms and a low serum testosterone level. They discuss the diagnosis of male hypogonadism, the indications for testosterone therapy, its potential benefits and risks, how it should be monitored, and how long it should be continued.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据